首页> 美国卫生研究院文献>other >The Immuno-Regulatory Impact of Orally-Administered Hypericum perforatum Extract on Balb/C Mice Inoculated with H1n1 Influenza A Virus
【2h】

The Immuno-Regulatory Impact of Orally-Administered Hypericum perforatum Extract on Balb/C Mice Inoculated with H1n1 Influenza A Virus

机译:口服贯叶连翘的免疫调节作用 甲型H1n1流感病毒Balb / C小鼠的贯叶连翘提取物

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Hypericum perforatum ( H . perforatum ) ethanol extract has been found to inhibit lipopolysaccharide-induced production of inflammatory mediators and cytokines in cultured macrophages. Therefore, it may be able to protect the host from excessive inflammation during viral infection. In the current study, the immune-regulatory effect of H . perforatum extract was evaluated in A549 lung epithelial cells and BALB/c mice exposed to Influenza A/PR/8/34 H1N1 virus. In A549 cells, the extract (30 µg/mL) significantly inhibited influenza virus induced monocyte chemotactic protein (MCP)-1 and interferon-γ induced protein 10 kD (IP-10), but dramatically increased interleukin-6 (IL-6). In mice inoculated intranasally with 107.9 EID50 of Influenza A/PR/8/34 H1N1 (high dose), daily oral treatment of H. perforatum extract at a rate of 110 mg/kg of body weight increased lung viral titer, bronchoalveolar lavage (BAL) pro-inflammatory cytokine and chemokine levels, and the infiltration of pro-inflammatory cells in the lung 5 days post-inoculation, as compared to ethanol vehicle treated mice. Transcription of suppressor of cytokine signaling 3 (SOCS3) was increased by H. perforatum extract both in A549 cells and BALB/c mice, which could have interrupted anti-viral immune response and thus led to the inefficient viral clearance and increased lung inflammation. H. perforatum treatment resulted in minor reduction in viral titer without affecting body weight when mice were inoculated with a lower dose (~105.0 EID50) and H. perforatum was applied in the later phase of infection. Mice challenged intranasally with high dose of influenza virus (107.9 EID50) suffered from a higher mortality rate when dosed with H. perforatum extract. In conclusion, the current study showed that SOCS3 elevation by H. perforatum may cause impaired immune defense against influenza virus infection and lead to higher mortality.
机译:已发现贯叶连翘(H. perforatum)乙醇提取物可抑制脂多糖诱导的培养巨噬细胞中炎性介质和细胞因子的产生。因此,它可以保护宿主免受病毒感染期间的过度炎症。在当前的研究中,H的免疫调节作用。在暴露于A / PR / 8/34 H1N1流感病毒的A549肺上皮细胞和BALB / c小鼠中评估了贯叶连翘提取物。在A549细胞中,提取物(30 µg / mL)显着抑制流感病毒诱导的单核细胞趋化蛋白(MCP)-1和干扰素-γ诱导的蛋白10 kD(IP-10),但白介素6(IL-6)显着增加。 。在经鼻内注射10 7.9 流感A / PR / 8/34 H1N1(高剂量)EID50的小鼠中,每日口服 H perforatum 提取物以110毫克/千克体重的速率增加,接种后5天肺病毒滴度,支气管肺泡灌洗液(BAL)的促炎细胞因子和趋化因子水平以及促炎细胞在肺中的浸润与乙醇载体处理的小鼠相比。细胞因子信号传导抑制因子3(SOCS3)的转录因 H perforatum 在A549细胞和BALB / c小鼠中均提取,可能会中断抗病毒免疫反应,从而导致无效的病毒清除和增加的肺部炎症。 H perforatum 处理可在小鼠以较低剂量(〜10 5.0 EID50)和 H perforatum 用于后期感染。鼻内注射高剂量流感病毒(10 7.9 EID50)的小鼠在服用 H perforatum 提取。总之,当前的研究表明, H perforatum 可能会削弱针对流感病毒感染的免疫防御能力,并导致更高的死亡率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号